In this issue:
Diagnostic relevance of cross-reactive autoantibodies in COVID-19 patients
IL-6–based mortality risk model for hospitalized patients with COVID-19
Egg oral immunotherapy superior to baked egg therapy for egg-allergic children
Long-term results from the PEPITAS extension study supports EPIT for peanut allergy in children
The asthmatic response to an experimental rhinovirus infection
POLYP 1 and POLYP 2 reveal efficacy of omalizumab in nasal polyposis
Combined immunodeficiency due to TFRC mutation
Consensus guideline for the management of primary antibody deficiency
A novel biomarker to predict response to immune checkpoint inhibitor therapy
Dupilumab improves clinical outcomes in patients with asthma and perennial allergic rhinitis
Please login below to download this issue (PDF)